CN Patent

CN112512528A — 糖皮质激素在治疗哺乳动物中具有天然外口的含流体器官的上皮微生物感染的新用途

Assigned to Virbac SA · Expires 2021-03-16 · 5y expired

What this patent protects

本发明涉及糖皮质激素用于治疗哺乳动物中具有天然外口的含流体器官中的上皮微生物感染；这种新的治疗用途在治疗耳(诸如外耳炎)、乳房(诸如乳腺炎)，和子宫(诸如子宫内膜炎)的上皮微生物感染方面特别有意义。

USPTO Abstract

本发明涉及糖皮质激素用于治疗哺乳动物中具有天然外口的含流体器官中的上皮微生物感染；这种新的治疗用途在治疗耳(诸如外耳炎)、乳房(诸如乳腺炎)，和子宫(诸如子宫内膜炎)的上皮微生物感染方面特别有意义。

Drugs covered by this patent

Patent Metadata

Patent number
CN112512528A
Jurisdiction
CN
Classification
—
Expires
2021-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Virbac SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.